Novavax
NVAX
#5696
Rank
NZ$2.37 B
Marketcap
NZ$14.41
Share price
-0.13%
Change (1 day)
24.13%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: NZ$2.37 Billion

As of November 2026 Novavax has a market cap of NZ$2.37 Billion. This makes Novavax the world's 5696th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.37 B24.09%
2025NZ$1.91 B-18.51%
2024NZ$2.35 B160.83%
2023NZ$0.90 B-34.49%
2022NZ$1.37 B-91.31%
2021NZ$15.83 B60.97%
2020NZ$9.83 B5045.81%
2019NZ$0.19 B-81.87%
2018NZ$1.05 B60.9%
2017NZ$0.65 B32.84%
2016NZ$0.49 B-85.09%
2015NZ$3.30 B83.09%
2014NZ$1.80 B39.04%
2013NZ$1.30 B282.48%
2012NZ$0.33 B83.12%
2011NZ$0.18 B-46.93%
2010NZ$0.34 B-4.75%
2009NZ$0.36 B63%
2008NZ$0.22 B-16.35%
2007NZ$0.26 B-25.11%
2006NZ$0.35 B16.64%
2005NZ$0.30 B70.61%
2004NZ$0.18 B-43.61%
2003NZ$0.32 B158.3%
2002NZ$0.12 B-84.32%
2001NZ$0.79 B86.56%
2000NZ$0.42 B159.71%
1999NZ$0.16 B265.94%
1998NZ$44.61 M-56.9%
1997NZ$0.10 B99.5%
1996NZ$51.87 M

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Novavax was reported to be:

NZ$2.38 Billion
by Nasdaq info icon info icon
NZ$2.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$516.84 B 21,635.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$285.94 B 11,924.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$490.58 B 20,530.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$173.80 B 7,209.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$2.83 B 19.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$3.97 B 67.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.49 B-78.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$55.58 M-97.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$3.42 B 43.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.47 B-79.85%๐Ÿ‡บ๐Ÿ‡ธ USA